CVE-2020-12866

Public Exploit

Description

A NULL pointer dereference in SANE Backends before 1.0.30 allows a malicious device connected to the same local network as the victim to cause a denial of service, GHSL-2020-079.

Category

5.7
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.22%
Vendor Advisory ubuntu.com Vendor Advisory opensuse.org Vendor Advisory opensuse.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://alioth-lists.debian.net/pipermail/sane-announce/2020/000041.html mailing list release notes third party advisory
https://securitylab.github.com/advisories/GHSL-2020-075-libsane third party advisory exploit
https://usn.ubuntu.com/4470-1/ third party advisory vendor advisory
http://lists.opensuse.org/opensuse-security-announce/2020-10/msg00079.html mailing list third party advisory vendor advisory
http://lists.opensuse.org/opensuse-security-announce/2020-11/msg00003.html mailing list third party advisory vendor advisory

Frequently Asked Questions

What is the severity of CVE-2020-12866?
CVE-2020-12866 has been scored as a medium severity vulnerability.
How to fix CVE-2020-12866?
To fix CVE-2020-12866, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-12866 being actively exploited in the wild?
It is possible that CVE-2020-12866 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.